Delivery Order SPE2DB22D3501-SPE2DB23FXK38

Award Date 9/28/23
Potential Completion Date 9/29/23
Potential Value $2.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,872 to Amerisourcebergen Drug Corporation for cyclophosphamide. The prime contractor will deliver the chemotherapy drug to a location in Conshohocken, Pennsylvania over a one day period in mid-August. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. The Defense Logistics Agency is a combat logistics support agency...
<p>The Defense Logistics Agency awarded a $2,219.04 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 mg vials of cyclophosphamide. The place of performance is Conshohocken, Pennsylvania and deliveries must be completed by June 16, 2023. No set-aside designation was used for this award to supply the generic chemotherapy drug to support the Defense Logistics Agency's medical supply chain programs.</p>
The Defense Logistics Agency awarded a $9,244.71 firm fixed price delivery order to Amerisourcebergen Drug Corp for 2 grams vials of the chemotherapy drug cyclophosphamide. As the prime contractor, Amerisourcebergen Drug Corp will deliver the vials to a location in Conshohocken, Pennsylvania by September 6, 2023 under the terms of this order issued against an existing DLA contract vehicle. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $21,093.40 to Amerisourcebergen Drug Corporation for 2,000 vials of the chemotherapy drug cyclophosphamide. Amerisourcebergen Drug, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical to a facility located in Conshohocken, Pennsylvania. Performance is required from August 7-8, 2023. The contract was awarded under an existing DLA vehicle to fulfill pharmaceutical needs for the Department of...
Defense Logistics Agency awarded a $3,698.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation, located in Conshohocken, Pennsylvania, for the delivery of 4559823453 cyclophosphamide 500 mg vials by February 6, 2023. The order was awarded on February 3, 2023 under an existing vehicle and has no set-aside designation. As a leading supplier of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to support the Defense Logistics Agency's mission of...
The Defense Logistics Agency awarded a $2,219 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 vials of the chemotherapy drug cyclophosphamide. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to its place of performance in Conshohocken, Pennsylvania by June 29, 2023 in support of the DLA's medical supply procurement programs. No subcontractors or set aside designations were indicated. Amerisourcebergen Corporation, the parent company,...
The Defense Logistics Agency awarded a $749 delivery order to Amerisourcebergen Drug Corporation for 500 mg vials of the pharmaceutical cyclophosphamide. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of DLA and other Department of Defense requirements. Performance will take place in Conshohocken, Pennsylvania over a three-day period from June 30 to July 3, 2023. The firm fixed price order was...
The Defense Logistics Agency Troop Support Medical awarded a $267 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 tablets of 50 mg cyclophosphamide. The place of performance is Conshohocken, Pennsylvania. The period of performance is August 22 through August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order for this chemotherapy medication from its facility in Conshohocken to support the...
The Defense Logistics Agency Troop Support Medical awarded a $7,558.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical cyclophosphamide. Place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania distribution facility. The order is to be filled on July 19th and completed by July 20th, 2023. Amerisourcebergen Corporation, which does business as Amerisourcebergen, is the parent company of Amerisourcebergen Drug...
The Defense Logistics Agency Troop Support Medical awarded a $163,850 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical cyclophosphamide. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from August 16, 2023 through August 17, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued against...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FXK38
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,553 to Amerisourcebergen Drug Corporation for cyclophosphamide. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility by September 29, 2023 in support of Defense Logistics Agency requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified in the award information.

Generated 12/28/23, 10:04 AM